- Home
- FCNCO vs SNN Comparison
FCNCO vs SNN Comparison
Compare FCNCO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCNCO | SNN |
|---|---|---|
| Founded | 1898 | 1856 |
| Country | United States | United Kingdom |
| Employees | 18141 | N/A |
| Industry | Major Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 14.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FCNCO | SNN |
|---|---|---|
| Price | $21.17 | $31.69 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.25 |
| AVG Volume (30 Days) | 13.3K | ★ 790.5K |
| Earning Date | 10-23-2025 | 03-02-2026 |
| Dividend Yield | ★ 6.17% | 2.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 169.27 | N/A |
| Revenue | ★ $8,897,000,000.00 | N/A |
| Revenue This Year | $0.56 | $7.19 |
| Revenue Next Year | $2.24 | $5.36 |
| P/E Ratio | ★ $0.13 | $64.97 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $20.57 | $23.91 |
| 52 Week High | $23.91 | $38.79 |
Technical Indicators
Market Signals| Indicator | FCNCO | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 25.10 | 32.93 |
| Support Level | $20.94 | $29.27 |
| Resistance Level | $21.50 | $33.89 |
| Average True Range (ATR) | 0.22 | 0.53 |
| MACD | -0.12 | -0.15 |
| Stochastic Oscillator | 2.15 | 0.90 |
Price Performance
Historical ComparisonAbout FCNCO First Citizens BancShares Inc. 5.625% Non-Cumulative Perpetual Preferred Stock Series C
First Citizens BancShares Inc. is a Raleigh, N.C.-based financial holding company operating through its subsidiary, First-Citizens Bank & Trust Company. It provides comprehensive retail banking, commercial lending, leasing, and wealth management services via a nationwide branch network and digital platforms. In 2023 acquisition of Silicon Valley Bank, it also specializes in banking for tech, healthcare, and innovation firms.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.